MRI T1 Contrast-Enhanced Signal Intensity Is a Prognostic Indicator of Imatinib Therapy in Desmoid-Type Fibromatosis

MRI T1 Contrast-Enhanced Signal Intensity Is a Prognostic Indicator of Imatinib Therapy in Desmoid-Type Fibromatosis

ObjectiveTo investigate the efficiency of pre-therapy magnetic resonance imaging (MRI) features in predicting the prognosis of desmoid-type fibromatosis patients treated with imatinib.Materials and MethodsA total of 38 desmoid-type fibromatosis patients treated with imatinib were collected in this r...

Full description

Bibliographic Details
Main Authors: Hui Ci Zhu, Shi Xing Xu, Xiao Ting Li, Zhen Guan, Shu Li, Ying-Shi Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
aggressive fibromatosis
systemic therapy
imatinib
response evaluation criterion in solid tumors (RECIST)
magnetic resonance imaging
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.615986/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.615986/full

Similar Items